H24E Innova

H24E Innova is a Spanish biotechnology company focused on the development of innovative treatments for chronic and hard-to-heal wounds. The company's primary focus is its lead candidate, H24E-01, a topical therapeutic designed to stimulate tissue regeneration and accelerate closure in diabetic foot ulcers and pressure sores. Headquartered in Granada, H24E Innova leverages advanced dermatological research to address significant unmet needs in wound care management. The company is currently conducting Phase 2 clinical trials to establish the clinical utility of its proprietary wound-healing technology. By targeting the biological pathways of impaired healing, H24E Innova aims to provide a more effective alternative to current standard-of-care treatments.